Skip to main content
TipRanks
Go Ultimate75% OFF

Citius Oncology (CTOR) Financial Statements

132 Followers

Citius Oncology Financial Overview

Citius Oncology's market cap is currently $50.92M. The company's EPS TTM is $-0.48; its P/E ratio is -1.20; Citius Oncology is estimated to report earnings on December 17, 2026, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Sep 25Sep 24Sep 23Sep 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -23.52M$ -20.57M$ -12.12M$ -9.71M
EBITDA$ -23.49M$ -20.57M$ -12.12M$ 0.00
Net Income$ -24.76M$ -21.15M$ -12.70M$ -10.87M
Balance Sheet
Cash & Short-Term Investments$ 3.92M$ 112.00$ 0.00$ 0.00
Total Assets$ 100.94M$ 84.37M$ 47.73M$ 42.69M
Total Debt$ 3.80M$ 3.80M$ 0.00$ 0.00
Net Debt$ -124.80K$ 3.80M$ 0.00$ 0.00
Total Liabilities$ 56.08M$ 38.23M$ 22.20M$ 6.42M
Stockholders' Equity$ 44.87M$ 46.14M$ 25.54M$ 36.27M
Cash Flow
Free Cash Flow$ -5.49M$ 126.35K$ -601.30K$ -47.97K
Operating Cash Flow$ -5.49M$ 126.35K$ -601.30K$ -47.97K
Investing Cash Flow$ -5.75M$ -5.00M$ -1.32M$ -67.32M
Financing Cash Flow$ 15.17M$ 4.87M$ 1.66M$ 67.66M

Currency in USD

Citius Oncology Earnings and Revenue History

-30M-20M-10M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2022202320242025RevenueEarningsProfit Margin

Citius Oncology Liabilities to Assets

040M80M120M0 %20 %40 %60 %LiabilitiesLiabilities to Assets2022202320242025AssetsLiabilitiesLiabilities to Assets

Citius Oncology Cash Flow

-75M-50M-25M025M50M75M2022202320242025OperatingInvestingFinancing

Citius Oncology Forecast EPS vs Actual EPS

-0.4-0.3-0.2-0.100.1Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss